Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: Benidipine (BD) and Telmisartan (TEL), co-administered antihypertensive medicines in the BCS class II group, are characterized by inadequate bioavailability due to restricted water solubility. Self-nano emulsifying drug delivery systems (SNEDDS) offer efficient solubilization for weakly water-soluble medicines due to their ternary ingredients' solubilization and nanonization activity, driven by surfactant and cosolvent. SNEDDS formulations comprise surfactants and cosolvents that facilitate nano droplet dispersion.